Is Quest Diagnostics Stock Outperforming the Nasdaq?

finance.yahoo.com · 2026-09-22

Quest Diagnostics has outperformed the Nasdaq over the past year, and analysts are moderately optimistic about the stock’s prospects.

TickrTrends take: Quest Diagnostics operates in the healthcare sector where diagnostic services remain essential to patient care and healthcare systems. TickrTrends currently rates DGX as overvalued, which suggests the stock price may not align with its underlying financial fundamentals. Investors focused on valuation should monitor whether operational performance in diagnostics can justify current pricing, particularly given the competitive pressures in the healthcare testing market.

Read the full story at finance.yahoo.com →